Skip to main content
. 2019 Feb 4;9:1225. doi: 10.1038/s41598-018-37883-y

Figure 1.

Figure 1

Expression of the immunogen, ovalbumin, in YUMM1.1 tumor cells promotes T cell-mediated tumor control. (a) Tumor growth and survival of 3 × 105 YUMM1.1 cells in C57BL/6 mice or NSG mice, with survival measured as time for tumors to reach >1200 mm3. ns – not significant, log-rank (Mantel-Cox) test, n = 5–8. (b) YUMM1.1-OVA sorted by FACS into low and high GFP-expressing populations; YOVAL1.1 and YOVAH1.1, respectively. (c) Killing by OT-I T cells co-cultured for 4 hours at indicated ratios with 51Cr-labelled target cells pre-stimulated +/− IFNγ. One way ANOVA, Tukey’s multiple comparisons test, n = 3. (d) YOVAL1.1 tumor growth and survival in C57BL/6 mice or NSG mice with survival measured as time for tumors to reach >1200 mm3, log-rank (Mantel-Cox) test, n = 3–5. (e) Growth of YOVAL1.1 in NSG or Rag1−/− mice, n = 3. (f) YOVAL1.1 tumor growth and survival following transfer of activated OT-I T cells or PBS. YV1.1 – YUMM1.1 transduced with empty vector. All error bars show ±SEM. **p < 0.01, ***p < 0.001.